Site Search
Search Results
2024 California Legislative Policy Roundtable and Awards
... We will also honor our Legislator of the Year State Senator Monique Limon (CA - SD19) for passage of Senate Bill 912 to improve access to Biomarker testing for Californians. Ways to Support ACS CAN's Impact We invite you to be part of a group of sustaining supporters enabling ACS CAN’s ...
Hundreds of Cancer Patients, Survivors to Congress: Make Cancer a National Priority
... Illinois State Representative Mary Flowers is being honored for her long-time commitment to health issues, including increased access to biomarker cancer testing. ACS CAN’s Judicial Advocacy Initiative award, which recognizes attorneys who generously donate their services to the cancer fight, is ...
Shana Crews Accepts National Staff Award for Excellence in Cancer Advocacy Work
... tirelessly with the Illinois general assembly to improve access to care for cancer patients by passing legislation that will expand coverage for biomarker testing. As a result, more Illinoisans will benefit from the latest advances in cancer treatment with this first in the nation law,” said Sara ...
Statement on the Passing of State Senator Maryellen Goodwin
... Island Cancer Caucus and shepherding invaluable legislation for Rhode Islanders, including improving their access to precision medicine through biomarker testing. In 2021, the American Cancer Society Cancer Action Network awarded Sen. Goodwin with our highest honor, the National Distinguished ...
2024 ACS CAN Hawaii Cancer Action Day Training
... all lawmakers: 2024 Hawaii Legislative Priorities Civil Beat article: Researchers Hope Hawaii Lawmakers Fund Cancer Research This Year Hawaii Biomarker Testing Fact Sheet Marijuana and Smoke-Free Laws Volunteer Advocate Packet - All you need to be ready for Cancer Action Day! Agenda ...
Virtual Policy Forum to Highlight the Role of Research in Equitable Access to High-Quality Cancer Care in California
... all levels of government that reduce disparities in cancer care. Among these are Senate Bill 912, a legislation that would ensure comprehensive biomarker testing is covered by more insurance plans – including Medi-Cal; and the California Cancer Care Equity Act (SB 987), which would ensure ...
American Cancer Society and ACS CAN Statement on National Cancer Institute Director Stepping Down
... “Prior to joining NCI, his research on mitigating the toxic effects of chemotherapy and advance targeted treatments through the use of biomarker testing characterizes his personal commitment to reducing the devastating effects of the more than 200 diseases we call cancer. He has significant ...
2023 ACS CAN California Cancer Action Day
... Issue Fact Sheets and Advocate Talking Points - including: Senate Bill 344 (Rubio): California Cancer Registry Senate Bill 496 (Limón): Biomarker Testing Senate Bill 421 (Limón): Oral Chemotherapy Fairness Act Volunteer Materials DRAFT Agenda Legislation Cheat Sheet Preparing for your ...
Oklahoma State Lead Ambassador
... early cancer detection for millions of Americans. On the state level, I’ve worked to push for policy solutions that remove barriers to biomarker testing in Oklahoma, helping to ensure cancer patients have access to precision medicine that can lead to better outcomes. Advocating for tobacco ...
Meet the Team
... Brian has also led or been a part of coalitions responsible for a number of access to care wins for patients at the state level including Biomarker Testing Coverage legislation in both Arizona and New Mexico and Medicaid Expansion in Arizona. Additionally, Brian has provided technical ...
Type
Priority Issue
State
- New York (35) Apply New York filter
- Ohio (18) Apply Ohio filter
- Pennsylvania (17) Apply Pennsylvania filter
- California (15) Apply California filter
- Washington (15) Apply Washington filter
- Hawaii (13) Apply Hawaii filter
- Maine (13) Apply Maine filter
- New Jersey (13) Apply New Jersey filter
- North Carolina (13) Apply North Carolina filter
- Tennessee (13) Apply Tennessee filter
- Illinois (11) Apply Illinois filter
- Colorado (10) Apply Colorado filter
- Florida (10) Apply Florida filter
- Massachusetts (10) Apply Massachusetts filter
- Connecticut (9) Apply Connecticut filter
- Delaware (9) Apply Delaware filter
- Georgia (8) Apply Georgia filter
- Kentucky (8) Apply Kentucky filter
- Maryland (7) Apply Maryland filter
- National (7) Apply National filter
- Vermont (7) Apply Vermont filter
- Nevada (6) Apply Nevada filter
- New Hampshire (6) Apply New Hampshire filter
- Arizona (5) Apply Arizona filter
- Iowa (5) Apply Iowa filter
- Mississippi (5) Apply Mississippi filter
- Oklahoma (5) Apply Oklahoma filter
- Oregon (5) Apply Oregon filter
- Texas (5) Apply Texas filter
- West Virginia (5) Apply West Virginia filter
- Indiana (4) Apply Indiana filter
- Minnesota (4) Apply Minnesota filter
- New Mexico (4) Apply New Mexico filter
- Nebraska (3) Apply Nebraska filter
- Rhode Island (2) Apply Rhode Island filter
- Alaska (1) Apply Alaska filter
- Louisiana (1) Apply Louisiana filter
- Michigan (1) Apply Michigan filter
- South Dakota (1) Apply South Dakota filter
Policy Issue
- Research, Funding and Drug Development (6) Apply Research, Funding and Drug Development filter
- Access to Health Care (2) Apply Access to Health Care filter
- Eye on Cancer Care (1) Apply Eye on Cancer Care filter
- Health Equity (1) Apply Health Equity filter
- Patient Quality of Life (1) Apply Patient Quality of Life filter